Bookmark

Add to MyYahoo RSS

Opko Health News

News on Opko Health (Ticker: OPK) continually updated from thousands of sources around the net.

14 hrs ago | Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Resumen: GSMA: los operadores de telecomunicaciones pueden una poltica TIC actualizada y progresiva para impulsar la economa, los trabajos y el bienestar social en Europa )--En la feria Digital Venice 2014 de esta semana, la GSMA y destacados operadores de telecomunicaciones europeos han presentado una declaraciA3n a Matteo Renzi, Prime... )--OPKO ... (more)

Comment?

Related Topix: Biotech

20 hrs ago | Freshnews

OPKO's Long-Acting Clotting Factor VIIa-CTP Receives Positive...

OPKO Health, Inc. today announced that the European Committee for Orphan Medicinal Products gave a positive opinion recommending the approval of orphan drug designation for OPKO's long-acting version of clotting Factor VIIa for the treatment of bleeding episodes in patients with hemophilia A or B with inhibitors to Factor VIII or Factor IX and ... (more)

Comment?

Related Topix: Biotech, Hemophilia, Health, Marketing, Opinion

Mon Jun 30, 2014

AmericanBankingNews.com

Investors Buy High Volume of Put Options on Opko Health

Opko Health saw some unusual options trading activity on Monday. Investors bought 5,001 put options on the company, American Banking & Market News reports.

Comment?

Related Topix: Biotech

Fri Jun 27, 2014

BioSpace

Opko Health, Inc. Granted Patent from European Patent Office For Lagova

OPKO Health, Inc. , a multinational biopharmaceutical and diagnostics company, today announced that the European Patent Office granted OPKO a patent covering the company's long-acting CTP-enhanced human growth hormone product , including composition of matter and associated methods.

Comment?

Related Topix: Biotech, Patent / Trademark Law, Law

Thu Jun 26, 2014

AmericanBankingNews.com

Insider Buying: Phillip Md Et Al Frost Purchases 65,000 Shares of Opko Health Stock

Opko Health CEO Phillip Md Et Al Frost acquired 65,000 shares of Opko Health stock on the open market in a transaction that occurred on Wednesday, June 25th.

Comment?

Related Topix: Biotech

Wed Jun 25, 2014

Business Wire

Strong Data from Lagovaa Phase II Clinical Study Presented during Webcast

During the webcast, Dr. Ron Rosenfeld, Chairman of OPKO Biologic's Scientific Advisory Board and professor emeritus of Pediatrics at both Stanford University and Oregon Health and Science University, highlighted the superior interim results from the study.

Comment?

Related Topix: Biotech, Stanford University, Oregon Health & Science University

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

De onderneming opereert op het kruispunt van mondiale problemen en werel... )--Research and Markets has announced the addition of the "Global Market Report of Methyl acetate --Research and Markets has announced the addition of the "Global Market Report of Pinocembrin ... )--OPKO Health, Inc. , a multinational biopharmaceutical and diagnostics ... (more)

Comment?

Related Topix: Biotech

Tue Jun 24, 2014

AmericanBankingNews.com

Opko Health CEO Phillip Md Et Al Frost Buys 15,000 Shares

Opko Health CEO Phillip Md Et Al Frost purchased 15,000 shares of Opko Health stock on the open market in a transaction dated Monday, June 23rd.

Comment?

Related Topix: Biotech

Fri Jun 20, 2014

Business Journal

See what billionaire Frost is investing in now

In South Florida, the most influential investor might be Miami Beach resident Dr. Phillip Frost .

Comment?

Related Topix: Biotech

Thu Jun 19, 2014

Freshnews

OPKO to Hold Conference Call to Discuss Six Month Data from Phase 2 hGH-CTP Trial

OPKO Health, Inc. , a multinational biopharmaceutical and diagnostics company that is developing a novel long-acting human growth hormone product for the treatment of growth hormone deficiency , today announced it will hold a conference call and webcast on Tuesday, June 24, 2014 at 8:30 a.m. EDT .

Comment?

Related Topix: Biotech, Medicine, Pharmacology

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Met meer dan 300 sprekers en 150 exposanten, zal h... )--Fitch Ratings has assigned a 'BBB+' credit rating to the $350 million aggregate principal amount 3.875% coupon senior unsecured notes due 2024 issued by Realty Income Cor... )--As Agent Bank, please be advised of the following rate determined on: 6/19/2014 Issue A QNB Finance Ltd - Series 18 ... (more)

Comment?

Related Topix: Biotech, United Therapeutics, Medicine, Healthcare Industry, Home, Mortgage, Personal Finance

Tue Jun 17, 2014

Hispanic Business

Opko Health, Inc. Files (8-K) Disclosing Submission of Matters to a...

OPKO HEALTH, INC. FILES Disclosing Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits held its 2014 Annual Meeting of Stockholders .

Comment?

Related Topix: Biotech

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••